Biosurgery items are utilized as a part of different surgeries to minimize the intra and post-operative difficulties. Different synthetic and biologic items like anti-adhesive agents, hemostatic specialists, bone unite substitutes, surgical sealing agents, and delicate tissue administration are used in surgeries for avoiding more blood loss or giving attachment or wound/tissue fixing, and repair of harmed or debilitated tissues or bones of a body. These advanced products boost the work productivity of doctors by controlling surgery-related challenges in costly and difficult surgeries.
How Big is the Global Biosurgery Market?
The Global Biosurgery Market is expected to exceed more than US$ 19.50 Billion by 2028 at a CAGR of 8.3% in the given forecast period.
The major driving factors of Global Biosurgery Market are as follows:
The restraining factors of Global Biosurgery Market are as follows:
The Global Biosurgery Market is segmented on the lines of its product type, source, application and regional. Based on product type segmentation it covers adhesion barriers, anti-adhesive agents, hemostatic agents, staple line reinforcement agents, surgical sealants, bone graft subsitutes, soft-tissue attachments (Soft Tissue Patch/Mesh). Based on source segmentation it covers biologics products, synthetics products. Based on application it covers neurological surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, reconstructive surgeries, urology surgeries.The Global Biosurgery Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Biosurgery Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for – Global Biosurgery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Biosurgery Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson and Johnson, Sanofi S.A., Stryker Corp., Cryolife Inc., Baxter International Inc., Hemostasis LLC, Atrium Medical Corporation (Maquet Getinge Group), C. R. Bard Inc., Medtronic PLC,
Kuros Bioscience, B. Braun Melsungen AG, Covidien PLC. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Biosurgery Market has been segmented as below:
By Product Type Analysis:
By Source Analysis:
By Application Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Biosurgery Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Biosurgery Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Hypertension Management Devices Market
Hyperthermia Treatment for Cancer market
Hysteroscopy Instruments Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Biosurgery Market Size Estimation
2.3 Biosurgery Market Breakdown and Data Triangulation
2.4 Biosurgery Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Biosurgery Products: Market Overview
4.2 Asia-Pacific: Natural/Biological Sealants Market, By Type (2015)
4.3 Geographic Snapshot of the Biosurgery Products Market
4.4 Regional Mix of the Biosurgery Products Market
4.5 Biosurgery Products Market: Developed vs Developing Countries
5 Market Overview
5.1 Introduction
5.2 Biosurgery Market Dynamics
5.3 Biosurgery Market Drivers
5.3.1 Rising Number of Surgeries
5.3.2 Approval of A Number of New and Advanced Biosurgery Products By Regulatory Authorities
5.3.3 Increasing Incidence of Sports-Related Injuries and Spinal Ailments
5.3.4 Increasing Focus on Effective Blood Loss Management in Patients During Surgeries
5.4 Market Restraint
5.4.1 Unfavorable Reimbursement Scenario for Biosurgery Products
5.5 Market Opportunity
5.5.1 Improving Healthcare Systems in Emerging Markets
5.6 Market Challenges
5.6.1 High Price of Biosurgery Products & Rising Cost of Surgical Procedures
5.6.2 Requirement of Skilled Personnel for Effective Use of Biosurgery Products
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Preference for Biological Meshes in Surgical Procedures
6.2.2 Introduction of New Technologies in the Biosurgery Products Market
6.2.3 Growth in the Number of Acquisitions in the Biosurgery Products Market
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 APAC
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
6.4 Vendor Benchmarking
7 Biosurgery Products Market, By Type
7.1 Introduction
7.2 Sealants
7.2.1 Natural/Biological Sealants
7.2.1.1 Natural/Biological Sealants, By Type
7.2.1.1.1 Fibrin Sealants
7.2.1.1.2 Gelatin-Based Sealants
7.2.1.1.3 Collagen-Based Sealants
7.2.1.1.4 Other Natural Sealants
7.2.1.2 Natural/Biological Sealants, By Origin
7.2.1.2.1 Human Blood-Based Sealants
7.2.1.2.2 Animal-Based Sealants
7.2.2 Synthetic and Semi-Synthetic Sealants
7.2.2.1 Cyanoacrylates
7.2.2.2 Polymeric Hydrogels
7.2.2.3 Urethane-Based Sealants
7.2.2.4 Other Synthetic and Semi-Synthetic Sealants
7.3 Hemostatic Agents
7.4 Adhesion Barriers
7.4.1 Synthetic Adhesion Barriers
7.4.1.1 Regenerated Cellulose
7.4.1.2 Hyaluronic Acid (HA)
7.4.1.3 Polyethylene Glycol (PEG)
7.4.1.4 Others
7.4.2 Natural Adhesion Barriers
7.4.2.1 Fibrin-Based Adhesion Barriers
7.4.2.2 Collagen & Protein
7.5 Soft Tissue Attachments (Patch/Mesh)
7.5.1 Synthetic Meshes
7.5.2 Biological Meshes
7.5.2.1 Allografts
7.5.2.2 Xenografts
7.6 Bone Graft Substitutes
7.6.1 Bone Allografts
7.6.2 Demineralized Bone Matrix (DBM)
7.6.3 Bone Morphogenetic Proteins (BMP)
7.6.4 Synthetic Bone Grafts
7.7 Staple Line Reinforcement Agents
8 Biosurgery Products Market, By Application
8.1 Introduction
8.2 Orthopedic Surgeries
8.3 General Surgeries
8.4 Neurological Surgeries
8.5 Cardiovascular Surgeries
8.6 Reconstructive Surgeries
8.7 Gynecological Surgeries
8.8 Urological Surgeries
8.9 Thoracic Surgeries
9 Biosurgery Products Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.2.1 Sealants and Hemostatic Agents
10.2.2 Bone Graft Substitutes
10.2.3 Adhesion Barriers
10.3 Competitive Situations and Trends
10.3.1 Agreements and Collaborations
10.3.2 Product Launches
10.3.3 Acquisitions
10.3.4 Expansions
10.3.5 Other Developments
11 Company Profiles
11.1 Introduction
11.2 Baxter International Inc.
11.3 C.R. Bard, Inc.
11.4 Covidien PLC (A Subsidiary of Medtronic, Inc.)
11.5 Johnson & Johnson Services, Inc.
11.6 Sanofi Group
11.7 Atrium Medical Corporation (A Part of Getinge Group)
11.8 B. Braun Melsungen AG
11.9 Cryolife, Inc.
11.10 Stryker Corporation
11.11 Hemostasis, LLC
The Global Biosurgery Market has been segmented as below:
By Product Type Analysis:
By Source Analysis:
By Application Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
